Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2162-2165
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2162
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2162
Variable | Parameter estimate (SE) | Conditional risk ratio (95% confidence limits) | P (χ2) |
mdm2 | 0.969 (0.324) | 2.636 (1.397-4.975) | 0.003 |
Age (yr) | 0.210 (0.013) | 1.021 (0.996-1.047) | 0.101 |
TNM | 0.279 (0.223) | 1.322 (0.853-2.048) | 0.212 |
Grade | 0.207 (0.193) | 1.229 (0.842-1.795) | 0.285 |
Site | -0.468 (0.469) | 0.627 (0.250-1.570) | 0.318 |
p53 | 0.336 (0.345) | 1.399 (0.712-2.751) | 0.330 |
Gender | -0.010 (0.352) | 0.990 (0.496-1.974) | 0.977 |
- Citation: Dong M, Ma G, Tu W, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(14): 2162-2165
- URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2162.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2162